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Introduction: Several studies have explored the design of antimicrobial peptides (AMPs) for the
development of therapeutic and diagnostic molecules for the treatment and identification of
pathogenic diseases as well as cancer. Human cadherin-1 protein has been identified to be involved
in adhesion-mediated signalling pathways in normal cells and its loss through genetic and
epigenetic alterations can result in an enhanced invasion and metastasis of malignancy in tumours.
Therefore, the identification of cadherin during treatment of cancer can be used as prognostic
biomarker to establish the responsiveness of patients to treatment regimen. Antimicrobial peptides
(AMPs) offer several compensatory advantages in biomedical applications and have been used for
treatment of diseases, dietary supplements and diagnosis of diseases. The aim of this research work
was to use in silico approaches to analyse retrieved human cadherin-1 as prognostic targets in
cancer treatments using modelled putative anticancer AMPs.
Methods: The structures of the putative AMPs and cadherin-1 were modelled using
I-TASSER server and the protein overall quality was validated using PROCHECK.
Thereafter, the protein motifs were predicted and the molecular interaction between the
putative anticancer AMPs and protein was carried out using PatchDock.
Results: The results revealed that all the AMPs were good prognostic molecules for cancer
with BOO1 having the highest binding affinity of 15,874.
Conclusion: This study revealed that all the generated AMPs have good prognostic value
for monitoring the progress of cancer treatment using human cadherin-1 as receptor. This is
the first report where AMPs were used in prognostics of cancer using human cadherin-1.
Keywords: cancer, antimicrobial peptides, prognosis, homology, modelling, docking,
physicochemical, binding, validation, cadherin-1
Introduction
According to the WHO statistics, cancer is rated the second leading cause of death in the
world with about 9.6 million death in 2018.1 This means one in six death cases is due to
cancer with the 70% of these happening in low and middle income country.2 It has led to
major economic losses in which International Health communities and Research insti-
tutes have spent a lot of money to combat its menace with a total economic cost of 1.16
trillion dollars spent in 2010 alone.3 One major factor leading to the enormous mortality
rate in the low income country is the late stage presentation, inaccessible diagnosis, lack
of precision to monitor treatment efficacy and overwhelming lack of data to drive policy.
Cancer is caused by many factors characterized by an abnormal growth of cells in
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lifestyle factors worsen the incidence of cancer as a major
public health problem posing a global menace associated with
metabolic and genetic abnormalities.4 One evidence linking
cancer to abnormal gene regulation is the disturbance of cell–
cell and cell extracellular matrix adhesion with the subse-
quent changes in adhesion-mediated signalling pathways of
cadherins which induce malignant phenotypes in normal
cells.5,6
Calcium independent adhesions (cadherins) are a class of
type-1 transmembrane proteins found in tumors and normal
cells which are highly dependent on Ca2+ ions to function and
use cell adhesion molecule (adherens junctions) for binding
cells together.7 Cadherin-mediated adhesion through the for-
mation of cadherin–catenin complex regulates cell growth and
differentiation, normal cell–cell adhesion, and maintain
homeostatic tissue architecture. Disruption of signalling and
altered expression of cadherins causes the disaggregation of
tumors which can be temporal or permanent to promote the
metastasis of such cells.8 This makes cadherins a major target
in cancer therapy. Over a hundred subtypes of this superfamily
have been identified from different species of organisms.7
Much research work has been conducted on the relationship
between cadherins and tumorigenesis as well as drug-targeting
cadherins which have undergone clinical trials.9 The loss of
cadherin in tumorigenesis due to genetic and epigenetic altera-
tions has been implicated in increased abnormal growth and
metastasis in cancer cells, thus preventing its regulatory role in
malignancy as a cancer cell suppressor. Identification of cad-
herin after treatment could be a potential approach in cancer
prognostics for enhanced treatment.
Antimicrobial peptides (AMPs) have recently been
explored as a source of therapy for many diseases due to
their compensatory multifunctional attributes. The advantages
of these vital molecules include signalling molecule, drug
delivery vector, immune-modulatory agent, antitumor and
mitogenic agents.10 The aim of this research work is to use
an in silico approach to identify AMPs modelled from
HMMER as selective inhibitors for more potent anti-cancer
therapy with high effectiveness, short-lived side effects and
high tolerability.
Materials and Methods
Retrieval of Cadherin-1 Sequences of
Homo sapiens and Computing of the
Physicochemical Parameters Analysis
The protein, cadherin-1, (P12830) amino acid sequences were
retrieved from the Universal Protein Databases (UniProt)
(https://www.uniprot.org/uniprot/P12830).11 Thereafter, the
protein physicochemical parameters were generated from the
ProtParam tools (http://web.expasy.org/protparam/) using
exPAsy Server to reveal the protein structure and function
with the computation of molecular weight, extinction coeffi-
cient, amino acid composition, estimated half-life, hydropathi-
city, theoretical PI, instability index and aliphatic index.12
Prediction of Secondary Structure
Secondary structure prediction such as alpha-helices, beta-
sheets and random coils of cadherin was predicted using
the PSIPRED secondary structure prediction server (http://
bioinf.cs.ucl.ac.uk/psipred).13
Assessment of Experimentally Validated
Antimicrobial Peptides (AMPs) Data
Experimentally validated anticancer AMPs from various data-
bases such as the Collection of Anti-microbial Databases
(CAMP) (http://www.camp.bicnirrh.res.in),14 Anti-microbial
Peptides Database (APD) (http://aps.unmc.edu/AP/main.
php)15 and Data Repository of Antimicrobial Peptides
(DRAMP) (http://dramp.cpu-bioinfor.org).16 Thereafter,
arrangement of these data and curation were performed to
validate the authenticity of the anticancer AMPs.
Subsequently, duplicate anticancer AMPs were removed
using Cluster Density at High Intensity with Tolerance (CD-
HIT) (http://www.bioinformatics.org/cd-hit).14
Hidden Markov Models (HMMER) Profile
Construction
The latest version of Hidden Markov Models (HMMER)
algorithm version 3.817 was used to construct specific antic-
ancer AMPs profiles using the respective training datasets,
having divided the retrieved experimentally validated antic-
ancer AMPs into three quarters (training dataset) and one
quarter (testing dataset). Query of the training dataset was
carried out using the positive dataset (testing dataset) and
negative dataset (neuropeptides). The HMMER profile was
built on the Ubuntu 12.04 LTS operating system. The task
was accomplished on a terminal and the command lines used
to build the profile was written in accordance with the corre-
sponding algorithm and the steps involved in their construction
are shown in Figure S1.
Discovery of Novel Anticancer AMPs
Proteome sequences were retrieved from the Ensembl
database (http://www.ensembl.org/index.html) and the
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UniProt database (http://www.uniprot.org/) and were used
to query the profile with the list of all proteome sequences
(in the FASTA format) retrieved. A cut-off E-value was set
to be 0.05 for the search of putative anticancer AMPs. This
was accomplished using “hmmsearch” module of the
HMMER algorithm with the command line employed as
stated in Figure S2.
Determination of the Physicochemical
Parameters of the Putative Anticancer
AMPs
3-D Structure Prediction of the Putative
Anticancer AMPs and Cadherin
The anticancer AMPs and cadherin (PDB ID: 1FF5)
(E-Cadherin double domain) 3-D structures were predicted
using ITASSER (https://zhanglab.ccmb.med.umich.edu/
I-TASSER/) and visualized using PyMol.19 The cadherin,
protein model structure was utilized for the de novo mod-
elling of the cadherin protein from the LOMETS threading
programs.20
Model Evaluation and Prediction of
Functional Motif
The quality of the generated model was checked using
PROCHECK to compute parameters such as side chain
conformations of the protein using atomic resolutions,
lengths, geometry of the hydrogen bond, angles and
planarity of the peptide bonds.21 The MOTIF (http://
www.genome.jp/tools/motif/) finder was used to find the
motifs present in the protein using the amino acid
sequences.22
In Protein-Ligand Interaction Study
The docking of the anticancer AMPs to the cadherin
protein was carried out using PatchDock 1.3 version,
a free online web-server that enables the docking of the
protein-small ligand molecule, available at http://bioin
fo3d.cs.tau.ac.il/PatchDock/.23 In brief, the 3-D structures
of the putative anticancer AMPs and the cadherin protein
receptor PDB files from I-TASSER were uploaded onto
the PatchDock server. Interaction analysis of the complex
formation between the putative anticancer AMPs and the
cadherin protein receptor was achieved using RasMol
2.7.5 software.24
Results
Physicochemical Properties of Cadherin-1
The result from ExPAsy server (Table 1) indicated that
cadherin-1 from Homo sapiens has 882 amino acids with
each residue contributing to give the protein an average
molecular weight of 97.456kDa. The result also indicated
that the most abundant amino acids are threonine, leucine,
valine, aspartate, proline, and glutamate, respectively. The
physicochemical parameters predicted the protein to be
negatively charged because of the abundance of glutamic




Number of amino acids 882




Ala=6.7, Arg=4.4, Asn=5.7, Asp=7.7,
Cys=0.9, Gln=3.5, Glu=6.8, Gly=6.1,
His=1.5, Ile=5.4, Leu=8.6, Lys=4.0,
Met=1.1, Phe=3.7, Pro=7.3, Ser=5.4,
Thr=9.1, Trp=1.1, Tyr=2.9, Val=7.9,
Atomic composition Carbon (C) = 4327, hydrogen
(H) = 6749, nitrogen (N) = 1151, oxygen








Extinction coefficient 94,240 (Abs 0.1% (=1g/L) 0.967, assuming
all pairs of cysteine residues form cystine)
93,740 (Abs=0.1% (=1g/L) 0.962,
assuming all cysteine residues are
reduced)
Total number of atoms 13,619
Estimated half-life 30 hours (mammalian reticulocytes,
in vitro)
>20 hours (yeast, in vivo)
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acid (6.8%) and aspartic acid (7.7%) over arginine (4.4%)
and lysine (4.0%) since these four amino acids contribute
the overall charge of the protein at neutral Ph.25 Also the
protein has 4327 carbon, 6749 hydrogen, 1151 nitrogen,
1374 oxygen and 18 sulphurs adding up to 13,619 atoms.
The protein is also acidic (4.57) with an half-life of 30
hours in mammals, greater than 20 hours in yeast and
greater than 10 hours in Escherichia coli indicating the
number of hours that it can stay intact in these organisms
without being degraded. The quantity of light that can be
absorbed by the protein is indicated by the extinction
coefficient was computed using tyrosine, tryptophan and
cysteine while the aliphatic index was 84.54 with −0.351
GRAVY and instability index of 35.43.
Secondary Structure Prediction of
Cadherin-1
The result in Figure 1 shows the predicted 2-D structure of
cadherin from the PSIPRED server where one alpha helix,
29 beta strand, and 32 random coils were recorded.
Cadherin is a transmembrane protein with an abundance
of beta strands just like human retinol binding protein and
porins.26,27 The abundance of beta strands in cadherin
allows it to perform its binding function through cell
adhesion.28
Putative AMPs Discovery and Their
Physicochemical Characterization
Retrieval of experimentally validated anticancer AMPs
from CAMP, APD and DRAMP databases was carried
out. It was revealed that APD, CAMP and DRAMP had
a total of 231 anticancer AMPs which were either vali-
dated, inferred or synthetic. Only experimentally validated
AMPs from the databases were retrieved for this study.
After duplicate removal, 56 experimentally validated
anticancer AMPs were generated. The peptides were
divided into three quarters (training set) and one quarter
(testing set). HMMER was used to build single profile of
the anticancer AMPs using the training set. The training
profile was used to scan the testing set (positive dataset)
which showed no discrimination for a high specificity,
accuracy and sensitivity. For improved sensitivity, accu-
racy and specificity, 17,234 neuropeptides in FASTA for-
mat were retrieved from the UNIPROT database (http://
www.uniprot.org) and ENSEMBL server (http://www.
ensembl.org/index.html) to test the discriminatory ten-
dency of the profile constructed by HMMER, called “the
query of profile”. The HMMER showed motif discrimina-
tion for the negative dataset (neuropeptides) since they
have no evolutionary relationship.
Subsequently, discovery of putative anticancer
AMPs was carried out using the training profile con-
structed by HMMER against several proteomes of organ-
isms downloaded from the ENSEMBL database to
discover putative anticancer AMPs, where the lowest
E values less than the default 0.05 were considered for
further study.Five putative anticancer AMPs were identi-
fied and ranked according to their E values from lowest to
the highest (Table S1).
Subsequently, the physicochemical parameters of the
AMPs were computed to determine their characteristics
required for the interaction study with the cadherin-1. For
the five putative anticancer AMPs generated (Table 2), none
have 100% similarity to the existing anticancer AMPs or
experimentally validated ones from which they were dis-
covered and as such can be considered novel. All the antic-
ancer AMPs had positive charge in conformity with an ideal
AMP. Also the AMPs had an abundance of lysine and
arginine strengthening further the contribution of these
amino acids to the positive charge of the AMPs and their
isoelectric point at alkaline pH.
The predicted hydrophobic value of the AMPs was
greater than 30% as anticipated for an ideal AMP and
these values contributed significantly to their high binding
potential to receptors and cells.29 This work is in accor-
dance with the work of Aruleba et al, 30 where AMPs were
used to investigate the structural and predicted binding
sites of Slc2a4 as a therapeutic target in the treatment of
cancer.
3-D Homology Prediction of the
Anticancer Putative AMPs and
Cadherin-1 Using I-TASSER
The prediction of the 3-D homology structure of the puta-
tive anticancer AMPs and the cadherin-1 was carried out
using ITASSER and visualized using PyMol. As indicated
in Figure S3, the result from the ITASSER gave rise to beta
strands of all the putative anticancer AMPs. This means that
the putative anticancer AMPs can modulate their interac-
tion, specificity and binding affinity to a receptor target. In
addition, the 3-D ITASSER result is in agreement with the
2-D result as indicated from the quality assessment scores
such as the confidence scores, template modelling scores
and the root mean square deviation. As indicated in Table 3,
Bakare et al Dovepress
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the confidence scores (C scores), the template modelling
scores (TM scores) and RMSD of the putative anticancer
AMPs and the cadherin 3-D homology models were of good
model quality. A C score of a quality structure prediction
model ranges between −5 and 2,31 TM score >0.5 indicates
a model of correct topology32 whereas RMSD only indi-
cates atomic deviation of the predicted 3-D homology of the
putative anticancer AMPs and cadherin-1 from the tem-
plates available in ITASSER.33 The models were of good
quality because the C score ranges between −5 and 2, TM
scores were all above the limiting value of >0.5 indicating
models of correct topology and RMSD values were
between 4.4Å and 15.3Å for all models of the anticancer
AMPs and cadherin-1.
Figure 1 Secondary structure prediction of cadherin 1 from PSIPRED. Cadherin 1 is predicted to have 29 beta strands and one alpha helix.
Dovepress Bakare et al
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3-D Modelled Structure Validation of
Cadherin-1
The quality of the model structure of cadherin1 was car-
ried out using the evaluation and validation of the
PROCHECK (h t t p s : / / s e r v i c e sn .mb i . u c l a . e du /
PROCHECK/). As indicated in Figure 2, the result from
the PROCHECK analysis indicates that the model of cad-
herin1 has 87.2% residues in the most favored regions,
12.8% in the additional allowed regions, 0.0% in the
generously allowed regions and 0.0% at the disallowed
regions. This model is said to be of high quality because
of the distribution of the amino acid residues. The G factor
was also determined using this program.
Probable Motifs Functional Analysis of
Cadherin-1
Table S2 shows the investigation of the probable func-
tional motif of cadherin-1 where the protein was said to
contain five functional motifs. Cadherin, the first func-
tional motif is located at position 161.253 in the amino
acid sequence with an E value of 4.1e-3, cadherin C is
located at position 734.878 in the amino acid sequence
withE value 6.7e-49, Cadherin pro located at position
27.116 in the amino acid sequence with E value 5e-31,
RET_CLD1 located at position 521.559 in the amino acid
sequence with E value 0.017 and cadherin-3 located at
position 357.428 in the amino acid sequence with
E value 0.39.
Protein-peptide Interaction of the
Putative Anticancer AMPs and
Cadherin-1
Table 4 shows online protein–protein interaction between
the cadherin-1 (receptor) and the putative anticancer
AMPs (ligands) using PatchDock. All results show
a high binding affinity score greater than 8741, indicating
a high binding solution between the putative anticancer
AMPs and cadherin-1. The result from this experiment can
be pursued for rational prediction of cadherin inhibitors in
the development of an efficacious anticancer therapy.
The results of the docking interaction analysis of the
cadherin-1 and the putative anticancer AMPs were down-
loaded in PDB files and visualized using RasMol software.













BOO1 5158.70 K 11.35 +6 39 2.36
BOO2 5082.60 K 11.35 +6 39 2.39
BOO3 5298.61 K 11.61 +10 34 1.72
BOO4 6743.78 R 10.75 +4 32 2.69
BOO5 5040.17 R 12.17 +9 30 3.26








BOO1 −1.11 0.58±0.14 4.5±3.0
BOO2 −1.53 0.53±0.15 5.4±3.4
BOO3 −1.00 0.59±0.14 4.4±2.9
BOO4 −1.37 0.55±0.15 5.6±3.5
BOO5 −1.53 0.53±0.15 5.3±3.4
Cadherin-1 −2.61 0.41±0.14 15.3±3.4
Figure 2 PROCHECK result for cadherin-1 using the generated model from
ITASSER. Residues in the most favored region (A, B, L), residues in the additional
allowed region (a, b, l, p), and the residues at the generously allowed regions
(~a, ~b, ~l, ~p).
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This is displayed in Figure S4 with the blue colour indi-
cating the protein, cadherin-1 and the red, putative antic-
ancer AMPs.
Discussion
Detection of cadherin through a prognostic biomarker can
give information about cancer patients'
improvements toward treatment regimens.34 Cadherin med-
iate cell–cell adhesion to regulate epithelial monolayer beha-
viour and most human solid tumors are epithelial in origin,
necessitating the attention of adhesion molecules at the
epithelial cell junctions.9 Cadherins are well conserved pro-
teins with their cytoplasmic domains interacting with beta
catenins at its central region to perform regulatory and stabi-
lity functions.35 One of the roles of cadherin in tumorigenesis
is its loss, which contributes to enhanced invasion andmetas-
tasis in human cancer, thus preventing it from binding
a newly synthesized beta catenin.36 The increased upregula-
tion of human cadherin-1 in malignancy has been linked to
the suppression of cancer cells.35 Therefore, detection of
cadherin could be a potential approach in cancer prognostics
for enhanced treatment. Numerous research works have used
AMPs in the treatment of diseases.37,38 Recently, AMPs have
been used for HIV detection using its P24 as receptor.39 The
aim of this research work was to detect cadherin using
putative AMPs as prognostic biomarkers for potential appli-
cations in monitoring cancer patients' improvements using in
silico approaches. This study is novel and significant because
it is the first report where AMPs were used as prognostic
biomarkers for human cadherin-1 detection to monitor
patients’ responsiveness during treatment of cancer. To this
end, analysis of human cadherin-1 was carried out with the
discovery of five putative anticancer AMPs and their inter-
action studies analysed using several types of bioinformatics
tools for precision prognosis.
The cysteine residue of cadherin-1 contributed less stabi-
lity due to its lower amount in the protein. Thus the stability
of human cadherin-1 could be due to the exposure of the
hydrophobic core, hydrogen bonding, net charge and the
ionization state of the amino acid residues.40 The presence
of noncovalent bonds between amino acids and chemical
forces between protein and its immediate environment in
human cadherin-1 could be another reason for its
stability.41 AMPs have gained interest as novel sources of
drugs and diagnostics of diseases. Its significance for these
therapeutic and diagnostic roles have been attributed to small
size and diverse activities triggered towards diseases.42 The
five putative anticancer AMPs discovered from this research
had a3> Boman index >1, an indicator that these peptides
would make a good prognostic biomarker for the detection of
cadherin-1 in humans. A Boman index of less than zero
might have antibacterial activities and that greater than zero
might have multifunctional and hormone-like activities.30,43
The alpha-helices and extended sheets of the putative antic-
ancer AMPs 3-D structures can help in the folding comple-
mentation, insertion and intermolecular interaction.44 This is
because alpha helices make efficient use of hydrogen bonds
for binding between hydrogen of the amino group and the
oxygen of the carboxyl group.30 Thus, the presence of alpha
helices in the AMPs make them interact with another biomo-
lecule for significant impact as targets in prognosis. The
3-D structure of the human cadherin-1 and the putative antic-
ancer AMPs showed good quality as indicated with the
C scores, TM-scores and RMSD values. The modelled
3-D structure of human cadherin-1 reliability was evaluated
using PROCHECK which deemed it a high quality model
because of the distribution of the amino acid residues in the
highly favoured, allowed, disallowed and generously
allowed regions.21 Subsequently, five major functional
motifs were predicted and several ligand active sites in the
human cadherin-1 protein were revealed.
Finally, the predicted putative anticancer AMPs were
used in this study to identify human cadherin-1, an impor-
tant protein for the cell–cell adherence and it can serve as
prognostic biomarker for monitoring the progress of can-
cer patients during treatment.
Furthermore, the protein–protein interaction PatchDock
server was used to dock the putative anticancer AMPs
(BOO1–BOO5) with human cadherin-1 in which high bind-
ing affinity scores greater than 8741 were generated for the
predicted 3-D structure of the AMPs when docked with
cadherin-1 3-D structure. This is an indication of high
binding solution for the AMPs with BOO1 having the high-
est score (Table 4). The results generated from this study
can be pursued for the rational design of novel, selective
and potent human cadherin-1 biomarker in the search for
Table 4 Docking Interaction Analysis of the Putative Anticancer
AMPs and Cadherin-1
AMPs Binding Scores Area ACE
BOO1 15,874 2648.90 −818.20
BOO2 14,080 2133.60 −120.01
BOO3 13,344 2070.60 98.81
BOO4 14,878 2044.60 195.63
BOO5 12,716 2132.50 19.16
Dovepress Bakare et al
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novel anticancer prognostic biomarker with high accuracy
and specificity.
Future Work
The in vitro study of the prognostic activity of the putative
anticancer AMPs will be carried out. In addition, the EC50 of
all the AMPs and their prognostic or selective indices will be
assessed for the optimized AMPs. The anticancer prognostic
potential of these AMPs will be carried out on different
pseudo types of the cancer cell lines to determine their
broad spectrum of prognostic activities. Finally, the binding
complex formed between the cancer cell lines and putative
AMPs will be solved using structural biology techniques to
validate the observations made by the in silico binding study.
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